Exploring the impact of childhood experiences on breast cancer patients
Adverse Childhood Experiences, AdaPtatiOn and Breast Cancer
This study looks at how tough childhood experiences might affect the emotional health and resilience of women who have been treated for breast cancer and are now in remission.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 128 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Lorraine Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Metz, Lorraine) |
| Trial ID | NCT05843539 on ClinicalTrials.gov |
What this trial studies
This observational study investigates how adverse childhood experiences (ACEs) affect emotional vulnerability and resilience in patients who have been diagnosed with breast cancer and are currently in remission. It aims to understand the relationship between attachment styles and psychological well-being during the remission phase, particularly focusing on the fear of cancer recurrence. The study will utilize biological and epigenetic measures to gather data on participants' emotional regulation and quality of life. By examining these factors, the research seeks to provide insights into the unique challenges faced by breast cancer survivors.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with breast cancer and are currently in remission.
Not a fit: Patients who are currently undergoing oncological treatment or have started psychotherapeutic treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance psychological support and interventions for breast cancer survivors, improving their quality of life.
How similar studies have performed: While studies have explored the impact of ACEs on mental health, this specific focus on breast cancer patients in remission is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have had breast cancer * Be considered in remission * Be over 18 years of age * Literate (able to understand the information and complete the questionnaire independently) * Agree to participate in the project and sign the informed consent form Exclusion Criteria: * Be a person subject to a legal protection measure * Be a protected adult, under guardianship or curators * Be undergoing oncological treatment * Have a lack of autonomy making it impossible to complete the questionnaire online * Have had or have begun psychotherapeutic treatment
Where this trial is running
Metz, Lorraine
- Ur 4360 Apemac — Metz, Lorraine, France (Recruiting)
Study contacts
- Principal investigator: Marion Trousselard, Pr — UR 4360 APEMAC, University of Lorraine
- Study coordinator: Marion Trousselard, Pr
- Email: marion.trousselard@intradef.gouv.fr
- Phone: 06 44 06 66 37
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.